|
|
||||||||
Original Research Communication |
1 From the SEAMEO-TROPMED Regional Center for Community Nutrition (EK) and the Department of General Internal Medicine, Faculty of Medicine (RHHN and ZA), University of Indonesia, Jakarta, Indonesia; the Departments of Gastroenterology (CEW) and of Internal Medicine (WMVD and JWMV), University Medical Center, Nijmegen, Netherlands; the Division of Human Nutrition and Epidemiology, Wageningen University, Wageningen, Netherlands (EK and CEW); Gesellschaft für Technische Zusammenarbeit (GTZ) GmbH, Eschborn, Germany (WS and RG); and the Laboratory of Clinical Chemistry and Hematology, Faculty of Medicine, University of Bonn, Bonn, Germany (HS).
Background: The results of cross-sectional studies indicate that micronutrient deficiencies are common in patients with tuberculosis. No published data exist on the effect of vitamin A and zinc supplementation on antituberculosis treatment.
Objective: Our goal was to investigate whether vitamin A and zinc supplementation increases the efficacy of antituberculosis treatment with respect to clinical response and nutritional status.
Design: In this double-blind, placebo-controlled trial, patients with newly diagnosed tuberculosis were divided into 2 groups. One group (n = 40) received 1500 retinol equivalents (5000 IU) vitamin A (as retinyl acetate) and 15 mg Zn (as zinc sulfate) daily for 6 mo (micronutrient group). The second group (n = 40) received a placebo. Both groups received the same antituberculosis treatment recommended by the World Health Organization. Clinical examinations, assessments of micronutrient status, and anthropometric measurements were carried out before and after 2 and 6 mo of antituberculosis treatment.
Results: At baseline, 64% of patients had a body mass index (in kg/m2) < 18.5, 32% had plasma retinol concentrations < 0.70 µmol/L, and 30% had plasma zinc concentrations < 10.7 µmol/L. After antituberculosis treatment, plasma zinc concentrations were not significantly different between groups. Plasma retinol concentrations were significantly higher in the micronutrient group than in the placebo group after 6 mo (P < 0.05). Sputum conversion (P < 0.05) and resolution of X-ray lesion area (P < 0.01) occurred earlier in the micronutrient group.
Conclusion: Vitamin A and zinc supplementation improves the effect of tuberculosis medication after 2 mo of antituberculosis treatment and results in earlier sputum smear conversion.
Key Words: Tuberculosis vitamin A zinc sputum smear conversion X-ray lesion area tuberculosis transmission micronutrient supplementation Indonesia
This article has been cited by other articles:
![]() |
N. Martins, P. Morris, and P. M Kelly Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor-Leste BMJ, October 26, 2009; 339(oct26_1): b4248 - b4248. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Clark, T. Karagoz, S. Apikoglu-Rabus, and F. V. Izzettin Effect of pharmacist-led patient education on adherence to tuberculosis treatment Am. J. Health Syst. Pharm., March 1, 2007; 64(5): 497 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Shenkin Micronutrients in health and disease. Postgrad. Med. J., September 1, 2006; 82(971): 559 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Villamor and W. W. Fawzi Effects of Vitamin A Supplementation on Immune Responses and Correlation with Clinical Outcomes Clin. Microbiol. Rev., July 1, 2005; 18(3): 446 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. H. Rosenberg Interdepartmental Committee on Nutrition for National Defense Surveys in Asia and Africa J. Nutr., May 1, 2005; 135(5): 1272 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schwenk, L. Hodgson, A. Wright, L. C Ward, C. F. Rayner, S. Grubnic, G. E Griffin, and D. C Macallan Nutrient partitioning during treatment of tuberculosis: gain in body fat mass but not in protein mass Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1006 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 603 - 662. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |